Search Results - "Hoogenraad, W.J."

The Impact of Boost Dose and Margins on the Local Recurrence Rate in Breast Conserving Therapy: Results From the EORTC Boost-No Boost Trial by Jones, H, Antonini, N, Colette, L, Fourquet, A, Hoogenraad, W.J, Van den Bogaert, W, Jager, J.J, Poortmans, P.M, Struikmans, H, Bartelink, H

Get full text

The impact of a boost dose on the local recurrence rate in high risk patients after breast conserving therapy – results from the EORTC boost-no boost trial by Jones, H, Antonini, N, Collette, L, Fourquet, A, Hoogenraad, W.J, Jager, J.J, Peterse, H.L, Poortmans, P.M, Struikmans, H, Bartelink, H

Get full text

O-113 Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the Randomized Boost Versus No Boost EORTC 22881–10882 Trial by Struikmans, H, Bartelink, H, Horiot, J.C, Poortmans, P.M, Van den Bogaert, W, Fourquet, A, Jager, J.J, Hoogenraad, W.J, Bing Oei, S, Wárlám-Rodenhuis, C.C, Pierart, M, Collette, L

Get full text

Can patient-, treatment- and pathology-related characteristics explain the high local recurrence rate following breast-conserving therapy in young patients? by Vrieling, C, Collette, L, Fourquet, A, Hoogenraad, W.J, Horiot, J.-C, Jager, J.J, Bing Oei, S, Peterse, H.L, Pierart, M, Poortmans, P.M, Struikmans, H, Van den Bogaert, W, Bartelink, H

“…The aim of this study was to identify patient-, tumour- or treatment-related factors associated with young age that might explain the higher risk of…”
Get full text

1155 Cancer wound and cancer ulcer treatment: a multidisciplinary approach by Lintz-Luidens, H., Peters, M.E., Tjan-Heijnen, V.C.G., Derksen, T., Hoogenraad, W.J.

Get full text

The influence of the boost technique on local control in breast conserving treatment in the EORTC ‘boost versus no boost’ trial by Poortmans, P.M, Bartelink, H, Horiot, J.C, Struikmans, H, Van den Bogaert, W, Fourquet, A, Jager, J.J, Hoogenraad, W.J, Rodrigus, P, Warlam-Rodenhuis, C, Collette, L, Pierart, M

Get full text

Significance of margins of excision on breast cancer recurrence (on behalf of the EORTC Radiotherapy, Breast Cancer Groups) by Jones, H.A, Antonini, N, Hart, G, Fourquet, A, Hoogenraad, W.J, Horiot, J.C, Poortmans, P.M, Jager, J.J, Van den Bogaert, W, Bartelink, H

Get full text

The higher local recurrence rate after breast conserving therapy in young patients explained by larger tumour size, incomplete excision at first attempt and smaller excision volume? by Vrieling, C., Collette, L., Fourquet, A., Hoogenraad, W.J., Horiot, J.C., Jager, J.J., Peterse, J.L., Pierart, M., Poortmans, P.M., Struikmans, H., van der Schueren, E., Bartelink, H.

Get full text

The influence of the boost on the cosmetic outcome after breast conserving therapy by Vrieling, C., Collette, L., Fourquet, A., Hoogenraad, W.J., Horiot, J.C., Jager, J.J., Pelerse, J.L., Pierart, M., Poortmans, P.M., Struikmans, H., van der Schueren, E., Bartelink, H.

Get full text

Results of a phase II trial of epirubicin and cisplatin (EP) before and after irradiation and 5-fluorouracil in locally advanced pancreatic cancer: An EORTC GITCCG study by Wagener, D.J.Th, Hoogenraad, W.J., Rougier, Ph, Lusinchi, A., Taal, B.G., Veenhof, C.H.N., de Graeff, A., Conroy, T., Curran, D., Sahmoud, T., Wils, J.

“…The objective of the present study was to define the role of chemotherapy, in the form of the EP regimen, consisting of epirubicin (E) and cisplatin (P) in…”
Get full text

Patient population analysis in EORTC trial 22881/10882 on the role of a booster dose in breast-conserving therapy by Ptaszynski, A, Van den Bogaert, W, Van Glabbeke, M, Pierart, M, Bartelink, H, Horiot, J C, Fourquet, A, Struikmans, H, Hamers, H, Müller, R P

“…The changing composition of the patient population in breast cancer, which has been reported over the last decade, has important consequences for prognosis. In…”
Get more information

Local control in T3 laryngeal cancer treated with radical radiotherapy, time dose relationship: the concept of nominal standard dose and linear quadratic model by Terhaard, C H, Karim, A B, Hoogenraad, W J, Tjho-Heslinga, R, Keus, R B, Mehta, D M, Reichgelt, B A, Hordijk, G J

“…In a retrospective study of the Dutch cooperative head and neck group 104 evaluable patients with T3NxMO squamous cell carcinoma of the larynx were treated…”
Get more information